510(k) device
Custom Stable Rigid Gas Permeable Scleral Contact Lens
Valley Contax, Inc. · Lens, Contact (Other Material) - Daily (HQD, Class II) · First FDA decision Mar 24, 2017, newest Jan 7, 2022Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
1
Naming "Custom Stable Rigid"
MAUDE reports
0
Brand "Custom Stable Rigid", since 2015
PubMed studies
0
Mentioning "Custom Stable Rigid"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Custom Stable Rigid Gas Permeable Scleral Contact Lens
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K213880 · Decided Jan 7, 2022 · 25 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
K170335 · Decided Mar 24, 2017 · 50 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Custom Stable Rigid", any status and sponsor, newest update first.
- enGIneering For sporT for AllCompleted
IRCCS Eugenio MedeaAcademic, hospital or other
NCT04794114 · 20 participants · Start Sep 1, 2020 · Primary completion Nov 30, 2021
Device: experimental ankle foot orthosis; traditional ankle foot orthosis · For: Cerebral Palsy
Sites: Bosisio Parini, Italy
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Custom Stable Rigid", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code HQD
37 reports: 3 malfunction, 34 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Custom Stable Rigid"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code HQD.
- Menicon Sf-P (Tm)Menicon Co, Ltd. · PMA 2000
- OPTIMUM GP (roflufocon D, roflurocon E) Daily Wear Contact LensContamac, Ltd. · 510(k) 2018
- Synergeyes Hybrid Contact Lenses - Daily Wear, Models A, M, Kc and PsSynergeyes, Inc. · 510(k) 2008
- Rigid Gas Permeable Contact Lens SolutionPolymer Technology Corp. · 510(k) 2001
- Acuity 200 (fluoroxyfocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc. · 510(k) 2024
- Visionary Optics Scleral Contact Lens (roflufocon D, roflufocon E, hexafocon A, hexafocon B, tisilfocon A, fluoroxyfocon A)Visionary Optics, LLC · 510(k) 2024
- Acuity 18 (enflufocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc. · 510(k) 2018
- FluoroPerm 30 & Paragon Thin (paflufocon C) RGP contact lenses with Tangible Hydra-PEGParagon Vision Sciences · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.